{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:21:55Z","timestamp":1783441315776,"version":"3.54.6"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1111\/j.1538-7836.2005.01376.x","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T04:34:38Z","timestamp":1123475678000},"page":"1763-1772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Autoimmune thrombocytopenia"],"prefix":"10.1016","volume":"3","author":[{"given":"B.H.","family":"CHONG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.\u2010J.","family":"HO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4065\/79.4.504","article-title":"Management of immune thrombocytopenic purpura in adults","volume":"79","author":"Stasi","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0015","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V88.1.194.194","article-title":"Prospective evaluation of clinical usefulness of an antigen\u2010specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocyotpenias","volume":"88","author":"Brighton","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1538-7836.2003.00091.x","article-title":"Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)","volume":"1","author":"McMillan","year":"2003","journal-title":"J Thrombo Haemost"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1055\/s-0037-1615754","article-title":"Clonal restriction of platelet associated anti\u2010GPIIb\/IIIa autoantibodies in patients with chronic immune thrombocytopenic purpura","volume":"85","author":"McMillan","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0040","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V100.4.1388.h81602001388_1388_1398","article-title":"Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation","volume":"100","author":"Roarke","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0045","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0050","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type\u20101 polarised immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0055","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI4238","article-title":"Autoreactive T cells to platelet GPIIb\/IIIa in immune thrombocytopenic purpura","volume":"102","author":"Kuwana","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood.V98.1.130","article-title":"Immunodominant epitopes on glycoprotein IIb\/IIIa recognised by autoreactive T cells in patients with immune thrombocytopenic purpura","volume":"98","author":"Kuwana","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0065","first-page":"1087","article-title":"H. pylori infection and immune thrombocytopenic purpura","volume":"88","author":"Franchini","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T\u2010cell\u2010mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0080","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult chronic ITP patients","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2003-01-0275","article-title":"Ultrastructural study shows morphologic features of apoptosis and para\u2010apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura","volume":"103","author":"Houwerzijl","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0037-1963(00)90103-3","article-title":"Advances in the diagnosis of idiopathic thrombocytopenic purpura","volume":"37","author":"Chong","year":"2000","journal-title":"Semin Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Haematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug\u2010induced thrombocytopenia: a systemic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0105","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood-2002-07-2175","article-title":"Drug\u2010induced thrombocytopenia: localization of the binding site of GPIX\u2010specific quinine dependent antibodies","volume":"102","author":"Asvadi","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0145-2126(02)00056-5","article-title":"Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes","volume":"26","author":"George","year":"2002","journal-title":"Leuk Res"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jcp.50.1.5","article-title":"Laboratory investigation of immune thrombocytopenia","volume":"50","author":"Warner","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.1997.d01-2064.x","article-title":"International study to compare antigen\u2010specific methods used for the measurement of antiplatelet autoantibodies","volume":"96","author":"Berchtold","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0130","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V60.4.1050.1050","article-title":"A prospective study of the usefulness of the measurement of platelet\u2010associated IgG for the diagnosis of idiopathic thrombocytopenic purpura","volume":"60","author":"Kelton","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0135","first-page":"97","article-title":"Platelet IgG: measurement, interpretation and clinical significance","volume":"10","author":"George","year":"1991","journal-title":"Prog Hemost Thromb"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/RAW2-0LQW-8YTX-941V","article-title":"Diagnostic value of tests for reticulated platelets, plasma glycocalicin and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia","volume":"115","author":"Kurata","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0145","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1055\/s-0037-1615023","article-title":"The diagnostic value of thrombopoietin level measurements in thrombocytopenia","volume":"79","author":"Porcelijn","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/blre.2001.0183","article-title":"Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura","volume":"16","author":"McMillan","year":"2002","journal-title":"Blood Rev"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1054\/blre.2001.0178","article-title":"Novel approaches to refractory immune thrombcytopenic purpura","volume":"16","author":"Bussel","year":"2002","journal-title":"Blood Rev"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0160","first-page":"397","article-title":"Adult chronic immune thrombocytopenic purpura","author":"McMillan","year":"2004","journal-title":"Haematology"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0165","first-page":"504","article-title":"Long\u2010term follow\u2010up of idiopathic thrombocytopenic purpura in 310 patients","volume":"86","author":"Vianelli","year":"2001","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0170","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0175","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","article-title":"Morbidity and mortality in adults with idiopathic thrombocytopenic purpura","volume":"97","author":"Portielje","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0180","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2003.04151_2.x","article-title":"Recombinant factor VIIa for refractory haemorrhage in autoimmune idiopathic thrombocytopenic purpura","volume":"120","author":"Culic","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9343(94)90048-5","article-title":"Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomized clinical trial","volume":"97","author":"Jacobs","year":"1994","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.10424","article-title":"Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti\u2010D with routine care","volume":"74","author":"George","year":"2003","journal-title":"Am J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0195","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood.V99.6.1922","article-title":"Does treatment with intermittent infusions of intravenous anti\u2010D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy","volume":"99","author":"Cooper","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V71.4.1165.1165","article-title":"Low doses v. conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults","volume":"71","author":"Belluci","year":"1988","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0205","first-page":"329","article-title":"Treatment of idiopathic thrombocytopenic purpura (ITP). Results of a multicentric protocol","volume":"70","author":"Mazzucconi","year":"1985","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0210","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJMoa030254","article-title":"Initial treatment of immune thrombocytopenic purpura with high dose dexamethasone","volume":"349","author":"Cheng","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0042-9007.2004.00391.x","article-title":"Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22\u2003years on","volume":"86","author":"Bierling","year":"2004","journal-title":"Vox Sanguinis"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0220","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0225","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-140-3-200402030-00012","article-title":"Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy","volume":"140","author":"Vesely","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0230","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with ITP","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1468-0734.2001.00043.x","article-title":"Management of adult immune thrombocytopenia","volume":"5","author":"Lechner","year":"2001","journal-title":"Rev Clin Exp Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0240","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjmed.2003.12.024","article-title":"Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long\u2010term results","volume":"116","author":"Maloisel","year":"2004","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0245","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM199406023302203","article-title":"Response of resistant idiopathic thrombocytopenic purpura to pulsed high\u2010dose dexamethasone therapy","volume":"330","author":"Andersen","year":"1994","journal-title":"New Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0250","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimaeric anti\u2010CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0255","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-2141.1997.412687.x","article-title":"Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases","volume":"97","author":"Godeau","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2141.2001.02893.x","article-title":"Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy","volume":"114","author":"Klappers\u2010Klunne","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0265","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1365-2141.2003.04211.x","article-title":"Long\u2010term follow\u2010up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy","volume":"120","author":"Bourgeois","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0270","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.V85.2.351.351","article-title":"Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura","volume":"85","author":"Reiner","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0275","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJM199304293281703","article-title":"Combination chemotherapy in refractory immune thrombocytopenic purpura","volume":"328","author":"Figueroa","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0280","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1365-2141.2002.03430.x","article-title":"Mycophenolate mofetil for the treatment of refractory autoimmune hameolytic anaemia and autoimmune thrombocytopenia","volume":"117","author":"Howard","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0285","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1034\/j.1600-0609.2003.00076.x","article-title":"Mycophenolate mofetil (MMF) for the treatment of steroid\u2010resistant idiopathic thrombocytopenic purpura","volume":"70","author":"Hou","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0290","doi-asserted-by":"crossref","first-page":"567a","DOI":"10.1182\/blood.V104.11.2059.2059","article-title":"Triple immunosuppressive therapy in patients with chronic resistant immune thrombocytopenic purpura: a case series of 11 patients","volume":"104","author":"Chan","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0295","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2141.1993.tb03117.x","article-title":"CAMPATH\u20101 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura","volume":"84","author":"Lim","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0300","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2141.2001.03039.x","article-title":"The effect of treatment with Campath\u20101H in patients with autoimmune cytopenias","volume":"114","author":"Willis","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0305","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V79.9.2237.2237","article-title":"Experience with protein A\u2010immunoadsorption in treatment\u2010resistant adult immune thrombocytopenic purpura","volume":"79","author":"Snyder","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2001-12-0171","article-title":"High dose cyclophosphamide with autologous lymphocyte\u2010depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia","volume":"101","author":"Huhn","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0315","doi-asserted-by":"crossref","first-page":"148a","DOI":"10.1182\/blood.V104.11.511.511","article-title":"A phase 2 placebo controlled study evaluating the platelet response and safety of weekly dosing with a novel thrombopoietic protein (AMG531) in thrombocytopenic adult patients with immune thrombocytopenic purpura (ITP)","volume":"104","author":"Kuter","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0320","first-page":"86A","article-title":"An open\u2010label, dose\u2010finding study evaluating the safety and platelet response of a novel thrombopoietic factor (AMG 531) in thrombocytopenic adult patients with immune thrombocytopenic purpura (ITP)","volume":"102","author":"Bussel","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0325","doi-asserted-by":"crossref","first-page":"567a","DOI":"10.1182\/blood.V104.11.2058.2058","article-title":"An open\u2010label, unit dose\u2010finding study evaluating the safety and platelet response of a novel thrombopoietic protein (AMG531) in thrombocytopenic adult patients with immune thrombocytopenic purpura","volume":"104","author":"Newland","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0330","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1182\/blood.V100.2.728","article-title":"Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura","volume":"100","author":"Nomura","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0335","doi-asserted-by":"crossref","first-page":"797a","DOI":"10.1182\/blood.V104.11.2916.2916","article-title":"An oral, non\u2010peptide, small molecule thrombopoietin receptor agonist increases platelet counts in healthy subjects","volume":"104","author":"Jenkins","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01376.x_bb0340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajh.10331","article-title":"Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept","volume":"73","author":"McMinn","year":"2003","journal-title":"Am J Hematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2005.01376.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622163063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622163063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2005.01376.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:34:00Z","timestamp":1761532440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622163063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1538783622163063"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01376.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01376.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}